Clinical Trial Update: Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH [NA]

View source ↗

Summary

A completed clinical trial evaluating the implanted nitinol iTind device for lower urinary tract symptoms due to benign prostatic hyperplasia in Chinese men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• iTind

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Prostate Hyperplasia | NA | Status: COMPLETED